deltaDOT is a spin out company from Imperial College London UK - a team of scientists and
engineers dedicated to the advancement of analytical techniques using patented methods and
instrumentation in High Performance Capillary Electrophoresis (HPCE). We design and
produce HPCE instruments which we are marketing worldwide. We also use the same
instruments to offer Analytical Services and Contract Research. Our offices and laboratories
are based in the London Bioscience Innovation Centre (LBIC).
engineers dedicated to the advancement of analytical techniques using patented methods and
instrumentation in High Performance Capillary Electrophoresis (HPCE). We design and
produce HPCE instruments which we are marketing worldwide. We also use the same
instruments to offer Analytical Services and Contract Research. Our offices and laboratories
are based in the London Bioscience Innovation Centre (LBIC).
Who we are
HPCE instruments
High Performance Capillary Electrophoresis (HPCE) analytical instruments are designed,
manufactured and marketed by deltaDOT. These instruments use deltaDOT’s proprietary
imaging and analysis technology called Label Free Intrinsic Imaging (LFII®). High
Performance Capillary Electrophoresis and Label Free Intrinsic Imaging applied to a CE
analytical system offers dramatically improved discovery power in comparison to other
conventional CE systems.
manufactured and marketed by deltaDOT. These instruments use deltaDOT’s proprietary
imaging and analysis technology called Label Free Intrinsic Imaging (LFII®). High
Performance Capillary Electrophoresis and Label Free Intrinsic Imaging applied to a CE
analytical system offers dramatically improved discovery power in comparison to other
conventional CE systems.
deltaDOT team of scientists has developed considerable expertise in CE based analysis and in
solving clients’ analytical problems. Using our own HPCE LFII® analytical instruments we also
offer Analytical Services and Contract Research to industry and academia from our
laboratories in the London Bioscience Innovation Centre.
solving clients’ analytical problems. Using our own HPCE LFII® analytical instruments we also
offer Analytical Services and Contract Research to industry and academia from our
laboratories in the London Bioscience Innovation Centre.
Analytical Services
& Contract Research
HPCE Applications
High Performance Capillary Electrophoresis (HPCE) is applied in Life Sciences research,
drug testing, diagnostics and bio-pharmaceutical manufacturing. This technology is used in
detection, separation and analysis of proteins, nucleic acids, carbohydrates, viruses and
bacteria, chemicals and a wide range of other analytes. More detail can be found on our
Technology pages.
drug testing, diagnostics and bio-pharmaceutical manufacturing. This technology is used in
detection, separation and analysis of proteins, nucleic acids, carbohydrates, viruses and
bacteria, chemicals and a wide range of other analytes. More detail can be found on our
Technology pages.
Application Notes
& Downloads
Antibody Analysis, Amino Acid Analysis, Transferrin, Small Molecules, Peptides, Complex
Protein Lysates, Recombinant Human Erythropoietin, Antibiotics in food products, Glycoforms,
DNA, RNA, Chemicals, Baculovirus Titre.
Protein Lysates, Recombinant Human Erythropoietin, Antibiotics in food products, Glycoforms,
DNA, RNA, Chemicals, Baculovirus Titre.
6th February 2013 deltaDOT to present at the International
Society for BioProcess Technology annual meeting.
Dr Stuart Hassard, Chief Scientific Officer, will be presenting the
use of LFII® in Process Analytical Technology (PAT) in the Flexible
Facilities and Systems Ancillary track at IsBioTech 2013 on Friday
the 15th of March 2013. The meeting will be held at Waterview
Conference Center 1919 North Lynn Street, Arlington, Virginia
22209, USA, March 11-15. Full details can be found at
www.isbiotech.org/
5th January 2013 - Employment Vacancy
deltaDOT Ltd. and The Royal Veterinary College (RVC) are seeking
applicants for an Analytical Chemistry Scientist position in the
department of Comparative Biomedical Sciences. RVC has
international reputation in veterinary pharmacology. The analyst
will work in collaboration with the RVC clinical pharmacologists and
deltaDOT Ltd., a biotechnology company specialising in capillary
electrophoresis (CE). deltaDOT has developed a Label Free Intrinsic
Imaging (LFII®) technology superior to existing CE technologies.
(...more)
23rd October 2012
deltaDOT sign distribution agreement with HORIBA UK
deltaDOT and HORIBA UK Ltd. of Stanmore, Middlesex have signed
a distribution agreement, with HORIBA being appointed sole UK
and Republic of Ireland distributor for deltaDOT's HPCE analytical
instruments. "Being associated with a large player in the field of
scientific instrumentation is very helpful, and deltaDOT is
expecting to benefit from HORIBA's brand, marketing expertise and
from the field support offered to deltaDOT technology by HORIBA's
sizeable engineering team" commented deltaDOT's Managing
Director Nigel Stokes.
24th September 2012
deltaDOT Ltd. announced the recent sale of their equity holding in
deltaDOT-QSTP LLC, its Doha based affiliate company to QS&T-
S.P.C. of Qatar. Mr Nigel Stokes, deltaDOT's Managing Director,
commented: "deltaDOT have worked closely with our colleagues in
Doha and are happy to have supported new developments on the
application of deltaDOT's Label free technology into the oil and gas
industry. We wish the company good fortune and look forward to
continued interactions and R&D programs" (...more)
2nd August 2012 deltaDOT Ltd. awarded Technology Strategy
Board grant
deltaDOT Ltd, announced today that the government-backed
Technology Strategy Board has awarded the company a feasibility
study award for the application of its Label Free Intrinsic Imaging
technology to bioprocess analytics. The project “Rapid low cost
formulation screening for protein self-interaction based on High
Performance Capillary Electrophoresis” is a feasibility study that
addresses the need for a cost effective, user-friendly, automated
platform technology allowing rapid screening for protein self-
interactions.
18 June 2012 Texas A&M System Awarded National Center for
Innovation. deltaDOT Ltd. is a partner in BARDA funded international
consortium. $285.6 million public-private partnership to enhance
the nation’s biosecurity preparedness and create jobs in Texas
(...more)
use of LFII® in Process Analytical Technology (PAT) in the Flexible
Facilities and Systems Ancillary track at IsBioTech 2013 on Friday
the 15th of March 2013. The meeting will be held at Waterview
Conference Center 1919 North Lynn Street, Arlington, Virginia
22209, USA, March 11-15. Full details can be found at
www.isbiotech.org/
5th January 2013 - Employment Vacancy
deltaDOT Ltd. and The Royal Veterinary College (RVC) are seeking
applicants for an Analytical Chemistry Scientist position in the
department of Comparative Biomedical Sciences. RVC has
international reputation in veterinary pharmacology. The analyst
will work in collaboration with the RVC clinical pharmacologists and
deltaDOT Ltd., a biotechnology company specialising in capillary
electrophoresis (CE). deltaDOT has developed a Label Free Intrinsic
Imaging (LFII®) technology superior to existing CE technologies.
(...more)
23rd October 2012
deltaDOT sign distribution agreement with HORIBA UK
deltaDOT and HORIBA UK Ltd. of Stanmore, Middlesex have signed
a distribution agreement, with HORIBA being appointed sole UK
and Republic of Ireland distributor for deltaDOT's HPCE analytical
instruments. "Being associated with a large player in the field of
scientific instrumentation is very helpful, and deltaDOT is
expecting to benefit from HORIBA's brand, marketing expertise and
from the field support offered to deltaDOT technology by HORIBA's
sizeable engineering team" commented deltaDOT's Managing
Director Nigel Stokes.
24th September 2012
deltaDOT Ltd. announced the recent sale of their equity holding in
deltaDOT-QSTP LLC, its Doha based affiliate company to QS&T-
S.P.C. of Qatar. Mr Nigel Stokes, deltaDOT's Managing Director,
commented: "deltaDOT have worked closely with our colleagues in
Doha and are happy to have supported new developments on the
application of deltaDOT's Label free technology into the oil and gas
industry. We wish the company good fortune and look forward to
continued interactions and R&D programs" (...more)
2nd August 2012 deltaDOT Ltd. awarded Technology Strategy
Board grant
deltaDOT Ltd, announced today that the government-backed
Technology Strategy Board has awarded the company a feasibility
study award for the application of its Label Free Intrinsic Imaging
technology to bioprocess analytics. The project “Rapid low cost
formulation screening for protein self-interaction based on High
Performance Capillary Electrophoresis” is a feasibility study that
addresses the need for a cost effective, user-friendly, automated
platform technology allowing rapid screening for protein self-
interactions.
18 June 2012 Texas A&M System Awarded National Center for
Innovation. deltaDOT Ltd. is a partner in BARDA funded international
consortium. $285.6 million public-private partnership to enhance
the nation’s biosecurity preparedness and create jobs in Texas
(...more)